Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH
Ankoor H. Patel; Gaurav N. Pathak; Alexander Chen; Patricia Greenberg; Natale Mazzaferro; Anish Patel; Naveen Mallangada; Carlos D. Minacapelli; Kaitlyn Catalano; Hansel Suthar; Vinod K. Rustgi;
10.1016/j.aohep.2024.101510
Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study
Samantha Thifani Alrutz Barcelos; Amanda Souza Silva-Sperb; Helena Abadie Moraes; Larisse Longo; Bruna Concheski de Moura; Matheus Truccolo Michalczuk; Carolina Uribe-Cruz; Carlos Thadeu Schmidt Cerski; Themis Reverbel da Silveira; Valesca Dall'Alba; Mário Reis Álvares-da-Silva;
Ann Hepatol. 2023;28:
Genetic risk factors for MASLD/MASH and cardiovascular disease in elderly individuals
Willy B. Theel; Vivian D. de Jong; Diederick E. Grobbee; J. Wouter Jukema; Stella Trompet; Manuel Castro Cabezas;
10.1016/j.aohep.2025.102170